SPHP in the News
WTEN: Women’s Health – National Kidney Month
Dr. Jorge Cerda, chief of the department of medicine at St. Peter’s Hospital, speaks to News10 about kidney disease and how best to prevent it.
Jorge Cerda
SPHP in the News
Times Union: COVID-19 Mortality Rates Are Down, but Will a Surge Undo Progress?
Jorge Cerda, M.D., chief of the department of medicine at St. Peter’s Hospital, was interviewed by the Times Union about treatment advances in the fight against COVID-19. Dr. Cerda discussed the benefits of proning, as well as medications like dexamethasone and monoclonal antibodies.
SPHP in the News
WTEN: Local Doctor Discusses Study on Kidney Failure Secondary to COVID-19
Jorge Cerda, M.D., chief of the department of medicine at St. Peter’s Hospital, appeared on WTEN/News10 to discuss the prevalence of acute kidney injury (AKI) among those hospitalized with COVID-19.
SPHP in the News
WNYT: Health Beat — Kidney Damage and COVID-19
Jorge Cerda, M.D., MS, FACP, FASN, chief of the department of medicine at St. Peter’s Hospital, appeared on WNYT’s Health Beat to discuss acute kidney injury linked to COVID-19.
SPHP in the News
WHYY: Treating Blood Clots, Kidney Injuries and Other Problems Linked to COVID-19 Could Save Lives
Jorge Cerda, M.D., chief of medicine at St. Peter’s Hospital, was interviewed by WHYY radio in Philadelphia about kidney problems associated with COVID-19, including excessive blood-clotting
SPHP in the News
WNYT: Plasma, Antiviral Drug Treatments Introduced at St. Peter’s Hospital
Jorge Cerda, M.D., chief of the Department of Medicine at St. Peter’s Hospital, was interviewed by WNYT about new treatments being offered to COVID-19 patients at St. Peter’s and Samaritan hospitals. This includes experimental convalescent plasma, and as well other antiviral and anti-inflammatory drug treatments.
News
St. Peter’s Health Partners Battling COVID-19 with Groundbreaking Therapies, Interdisciplinary Care
Multiple groundbreaking therapies to treat the sickest COVID-positive patients in the Capital Region are being employed at St. Peter’s Health Partners’ (SPHP) acute care hospitals in Albany and Troy. They include the antiviral drug remdesivir; IL-6 inhibitor drugs; macrophage inhibitors; and convalescent blood plasma therapy.